People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Biotechnology, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immunocore Holdings plc | — | Biotechnology | Series D+ | $140.0M | $2.9B | 2022 |
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2011 |
| EyePoint Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $25.6M | $438.3M | 2018 |
Kristine Peterson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kristine Peterson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| Todd Foley | 1 | 12 |
| Scott Jones | 1 | 11 |
| David Berman | 1 | 8 |
| Ittai Harel | 1 | 6 |
| Daniel Pelak | 1 | 5 |
| James Barry | 1 | 5 |
| John Bell | 1 | 5 |
| Douglas Godshall | 1 | 4 |
| John Barr | 1 | 3 |
| Michael Bigham | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| Bahija Jallal | 1 | 3 |
| Robert Perez | 1 | 3 |
| Sean Traynor | 1 | 3 |
| Michael Rogers | 1 | 3 |
| David Mazzo | 1 | 3 |
| Jay Duker | 1 | 2 |
| James Dentzer | 1 | 2 |
| Paul Queally | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.